EAGLE PHARMACEUTICALS, INC.EGRX

Market cap

$61.82M

P/E ratio

	Sep 30, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Product	-	-	-	-	70	74	72	65	215
Royalty revenue	-	-	-	-	143	113	110	107	98
License	-	-	-	-	-	9	5	-	4
Total revenue	-	66	189	237	213	196	188	172	317
Cost of product sales	-	-	-	-	42	48	34	32	85
Royalty Expense	-	-	21	23	20	13	12	11	9
Research and development	-	28	30	33	44	37	31	51	34
Selling, general and administrative	-	20	52	71	61	76	79	75	107
Total operating expenses	-	-	-	-	-	174	155	169	236
Income from operations	-	3	53	74	37	22	33	3	81
Interest income	-	0	0	0	0	2	1	1	0
Interest expense	0	0	0	1	3	3	3	2	4
Other expense	-	-	-	-	-	-	-8	-6	-16
Total other expense, net	-	0	0	-1	-3	0	-10	-7	-20
Income (loss) before income tax provision	-	3	53	73	34	22	23	-5	61
Income tax provision	-	0	-28	21	2	8	11	4	26
Net income (loss)	-18	3	81	52	32	14	12	-9	36
Earnings Per Share, Basic	-	0.17	5.24	3.44	2.16	1.04	0.89	-0.66	2.76
Earnings Per Share, Diluted	-	0.16	4.96	3.27	2.09	1.01	0.87	-0.66	2.73